Follow this preprint
Robust immune responses after one dose of BNT162b2 mRNA vaccine dose in SARS-CoV-2 experienced individuals
Marie I. Samanovic, Amber R. Cornelius, View ORCID ProfileSophie L. Gray-Gaillard, Joseph Richard Allen, Trishala Karmacharya, Jimmy P. Wilson, Sara Wesley Hyman, Michael Tuen, View ORCID ProfileSergei B. Koralov, View ORCID ProfileMark J. Mulligan, View ORCID ProfileRamin Sedaghat Herati
doi: https://doi.org/10.1101/2021.02.07.21251311
Now published in Science Translational Medicine doi: 10.1126/scitranslmed.abi8961
Marie I. Samanovic
1NYU Langone Vaccine Center, Department of Medicine, New York University Grossman School of Medicine; New York, NY, USA
Amber R. Cornelius
1NYU Langone Vaccine Center, Department of Medicine, New York University Grossman School of Medicine; New York, NY, USA
Sophie L. Gray-Gaillard
1NYU Langone Vaccine Center, Department of Medicine, New York University Grossman School of Medicine; New York, NY, USA
Joseph Richard Allen
1NYU Langone Vaccine Center, Department of Medicine, New York University Grossman School of Medicine; New York, NY, USA
Trishala Karmacharya
1NYU Langone Vaccine Center, Department of Medicine, New York University Grossman School of Medicine; New York, NY, USA
Jimmy P. Wilson
1NYU Langone Vaccine Center, Department of Medicine, New York University Grossman School of Medicine; New York, NY, USA
Sara Wesley Hyman
1NYU Langone Vaccine Center, Department of Medicine, New York University Grossman School of Medicine; New York, NY, USA
Michael Tuen
1NYU Langone Vaccine Center, Department of Medicine, New York University Grossman School of Medicine; New York, NY, USA
Sergei B. Koralov
2Department of Pathology, New York University School of Medicine; New York, NY, USA
Mark J. Mulligan
1NYU Langone Vaccine Center, Department of Medicine, New York University Grossman School of Medicine; New York, NY, USA
Ramin Sedaghat Herati
1NYU Langone Vaccine Center, Department of Medicine, New York University Grossman School of Medicine; New York, NY, USA

Data Availability
Data from this study is available upon request.
Posted August 31, 2021.
Robust immune responses after one dose of BNT162b2 mRNA vaccine dose in SARS-CoV-2 experienced individuals
Marie I. Samanovic, Amber R. Cornelius, Sophie L. Gray-Gaillard, Joseph Richard Allen, Trishala Karmacharya, Jimmy P. Wilson, Sara Wesley Hyman, Michael Tuen, Sergei B. Koralov, Mark J. Mulligan, Ramin Sedaghat Herati
medRxiv 2021.02.07.21251311; doi: https://doi.org/10.1101/2021.02.07.21251311
Now published in Science Translational Medicine doi: 10.1126/scitranslmed.abi8961
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
71
Blogs/Media
0
Author Videos
Subject Areas
- Addiction Medicine (420)
- Allergy and Immunology (744)
- Anesthesia (217)
- Cardiovascular Medicine (3208)
- Dermatology (270)
- Emergency Medicine (476)
- Epidemiology (13211)
- Forensic Medicine (19)
- Gastroenterology (887)
- Genetic and Genomic Medicine (5038)
- Geriatric Medicine (469)
- Health Economics (770)
- Health Informatics (3167)
- Health Policy (1121)
- Hematology (419)
- HIV/AIDS (997)
- Medical Education (467)
- Medical Ethics (125)
- Nephrology (512)
- Neurology (4783)
- Nursing (253)
- Nutrition (708)
- Oncology (2462)
- Ophthalmology (698)
- Orthopedics (277)
- Otolaryngology (336)
- Pain Medicine (318)
- Palliative Medicine (89)
- Pathology (528)
- Pediatrics (1272)
- Primary Care Research (546)
- Public and Global Health (7343)
- Radiology and Imaging (1660)
- Respiratory Medicine (962)
- Rheumatology (471)
- Sports Medicine (413)
- Surgery (532)
- Toxicology (69)
- Transplantation (227)
- Urology (199)